ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 9.52
+0.41 (4.50%)
At close: Aug 4, 2026
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 4.54 billion as of August 4, 2026. Its market cap has decreased by -31.50% in one year.
Market Cap
4.54B
Enterprise Value
4.55B
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.52
ChartMarket Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 4.54B, an increase of 113.93%. That is a compound annual growth rate of 4.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 4.54B | -4.71% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 4.80B |
| Beijing Konruns Pharmaceutical | 4.69B |
| Suzhou Fengbei Biotech Stock | 4.67B |
| Xiangxue Pharmaceutical | 4.62B |
| R&G PharmaStudies | 4.53B |
| Shenzhen Weiguang Biological Products | 4.52B |
| PharmaResources (Shanghai) | 4.37B |
| Anhui Huaheng Biotechnology | 4.24B |